What is skip metastasis?

Skip Metastasis: Definition and Clinical Significance

Skip metastasis refers to lymph node metastases occurring at a distant or lower nodal level without involvement of the intervening or expected sequential lymph node stations along the typical drainage pathway.

Core Concept

Skip metastasis represents a deviation from the orderly, sequential pattern of lymphatic spread typically observed in cancer. Instead of progressing through adjacent nodal stations, tumor cells "skip" intermediate nodes and establish metastases at more distant sites 1.

Cancer-Specific Patterns and Incidence

Nasopharyngeal Carcinoma

• Extremely rare occurrence: Skip metastasis (lower-neck nodal metastases without upper-neck involvement) occurs in only 0.5–0.8% of cases 1
• Nodal metastasis typically follows an orderly pattern: retropharyngeal nodes first → upper-neck levels II, III, or Va → lower-neck levels IV and Vb 1

Papillary Thyroid Carcinoma

• Incidence ranges from 10–15%: Skip metastasis defined as lateral lymph node metastasis without central compartment involvement 2, 3, 4
• Independent predictors include 2, 4:
  • Tumor size ≤10 mm
  • Upper pole location of primary tumor
  • Presence of Hashimoto's thyroiditis
  • Absence of BRAF V600E mutation
  • Fewer central lymph nodes dissected
• Prognostic implications: Recurrence rate similar to central-only metastasis (N1a) and significantly lower than combined central-lateral metastasis (N1b-CL) 3

Gastric Cancer

• Skip metastasis involves extraperigastric lymph node metastasis without perigastric involvement 5
• Critical consideration: May represent inadequate lymph node sampling rather than true biological skipping, as patients with skip metastasis had significantly fewer retrieved lymph nodes, especially from the perigastric area 5
• Prognosis: Worse than perigastric-only metastasis and similar to combined perigastric-extraperigastric metastasis when tumor stage is considered 5

Non-Small Cell Lung Cancer

• Skip metastasis defined as N2 disease (mediastinal nodes) without N1 involvement (hilar/intrapulmonary nodes) 6, 7
• The 8th edition staging proposes subclassification: N2a1 (single N2 station without N1) versus N2a2 (single N2 station with N1) 6

Oral Cancer

• Very low incidence: Skip metastasis to level III occurs in 1.2% and level IV in 0.3% of clinically node-negative early oral cancers 8
• Presence of perineural invasion predicts skip metastasis to level III 8
• Clinical impact: Isolated level IV metastasis significantly reduces 5-year disease-free survival (50% vs 79.6%) 8

Breast Cancer

• Extremely rare: Only 1 skip metastasis (0.21%) documented in 466 patients undergoing sentinel lymph node mapping, occurring in a patient with prior excisional biopsy 9

Clinical Implications

Surgical Planning

• The rarity of skip metastasis in most cancers supports selective lymph node dissection strategies 1, 8
• For oral cancer, clearance up to level III may be adequate in the vast majority of clinically node-negative patients given the 0.3% incidence of skip to level IV 8
• For nasopharyngeal carcinoma, elective upper-neck irradiation alone (without whole-neck treatment) is safe for N0-1 disease 1

Diagnostic Considerations

• Sampling adequacy matters: Apparent skip metastasis may reflect insufficient lymph node retrieval rather than true biological behavior 5
• In thyroid cancer, skip metastasis can be predicted preoperatively using clinical and molecular factors, potentially guiding surgical extent 2, 4

Prognostic Significance

• Varies by cancer type: In thyroid cancer, skip metastasis has favorable prognosis similar to central-only disease 3
• In gastric cancer, skip metastasis carries worse prognosis similar to more extensive nodal involvement 5
• In oral cancer, isolated level IV skip metastasis significantly worsens survival 8

Common Pitfalls

Avoid assuming skip metastasis is always a true biological phenomenon — it may represent inadequate lymph node sampling, particularly when fewer nodes are examined 5. The uncertainty descriptor [e.g., pN0(un)] should be used when fewer than six nodes/stations are sampled at resection 7.

Do not extrapolate skip metastasis patterns across cancer types — the incidence, predictors, and prognostic implications are highly cancer-specific 1, 2, 8, 3, 5.